News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Emdeon Corporation IPO Rises 6.6%, Ending Off Day’s High
August 24, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Wall Street Journal - Investors flocked to the IPO of Emdeon Inc., driving up shares of the medical-billing company by 6.6%.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Deals
Lilly Doubles Down on Insilico’s AI Medicines, Bets Up to $2.75B
March 30, 2026
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Novartis Keeps Deals Coming With $2B Excellergy Takeover
March 27, 2026
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Merck To Buy Terns, ‘Unprecedented’ Leukemia Drug for $6.7B as Keytruda Cliff Looms
March 25, 2026
·
3 min read
·
Tristan Manalac
Mergers & acquisitions
Gilead Drops $2.1B for Ouro, Hopes To Split Cost with Galapagos
March 24, 2026
·
3 min read
·
Tristan Manalac
